维普中文期刊产品整合服务
31篇 您的检索式:作者名="Duda Y"
    题名 作者 年代 出处 被引量
1Adaptation of HIV-1to human leukocyte antigen class I显示文摘Kawashima Y Pfafferott K Frater J Matthews P Payne R Addo M Gatanaga H Fujiwara M Hachiya A Koizumi H Kuse N Oka S Duda A Prendergast A Crawford H Leslie A Brumme Z Brumme C Allen T Brander C Kaslow R Tang J Hunter E Allen S Mulenga J Branch S Roach T John M Mallal S Ogwu A Shapiro R Prado J G Fidler S Weber J Pybus O G Klenerman P Ndung'u T Phillips R Heckerman D Harrigan P R Walker B D Takiguchi M Goulder P 2009Nature2009,458,7238:1
2Surrogate markers for antian giogenic therapy and dose-limiting toxicities for bevacizumab withradiation and chemotherapy: continued experience of a phase 1 trial in rectal cancer patients显示文摘Willett CG Boucher Y Duda DG 2005J Clin Onco12005,23,31:1
3C-X-C receptor type 4 promotes metastasis by activating p38 mitogen- activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells 显示文摘Hiratsuka S Duda DG Huang Y 2011Proc Natl Acad Sci USA2011,108,1:1
4Signaling through Tgf- type I receptor Alk5 is required for upper lip fusion 显示文摘LI W Y DUDAS M KAARTINEN V 2008Mecha- nisms of Dev2008,125,910:1
5An equation relating self diffusion and mutual diffusion coefficients in polymer-solvent systems显示文摘Duda J Ni Y Vrentas J 1979Macromole cules1979,12,3:1
6Surrogate markers for anlian- giogenic therapy and dose-limiting toxicities for bevacizumab with ra- diation and chemotherapy:continued experience of a phase I trial in rectal caneer patients 显示文摘Willett CG Boucher Y Duda DG 2005Journal of Clinical Oncology2005,23,31:1
7Safety and immunogenicity of live attenuated quadrivalent human-boving(UK) reassortant rotavirus vaccine administered with childhood vaccines to infants 显示文摘Clements Mann M L Dudas R Hoshino Y 2001Vaccine2001,19,32:1
8Safety and immunogenicity of live attenuated quadrivalent human - bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants 显示文摘Clements-Mann ML Dudas K Hoshino Y et ol 2001Vaccine2001,19,32:1
9Surrogate markers for anti- angiogenie therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy : continued experience of a phase I trial in rectal caneer patients 显示文摘Willett CG Boueher Y Duda DG 2005J Clin Oncol2005,23,31:1
10Blockade of VEG- FR2 and not VEGFR1 can limit diet-induced fat tissue ex-pansion: role of local vers us bone marrow-derived endo- thelial cells 显示文摘Tam J Duda D G Perentes J Y PLoS One0,4,3:1
11Internal forces and moments in the femur during walking显示文摘Duda G N Schneider E Chao E Y 1997J Biomech1997,30,9:1
12Corrosion inhibitors: Design, performance, and computer simulation 显示文摘DUDA Y GOVEA-RUEDA R GALICIA M 2005J Phys Chem2005,109,22:1
13Vascular normalization as an emerging strategy to enhance cancer immunotherapy显示文摘Huang Y Goel S Duda DG 2013Cancer Res2013,73,10:1
14Surrogate markera for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy:Continued experience of a phase I trial in rectal cancer patients显示文摘Willett CG Boncher Y Duda DG 2005J Clin Oncol2005,23,31:1
15Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy:continued experience of a phase Ⅰ trial in rectal cancer patients显示文摘Willett CG Boucher Y Duda DG 0,,31:1
16Vascular normalization as anemerging strategy to enhance cancerimmunotherapy显示文摘Huang Y Goel S Duda DC etal 2013Cancer Res2013,73,10:1
17Thermodynamics of asphaltene structure and aggregation显示文摘Duda Y Lira-Galeana C 2006Fluid Phase Equilibr2006,241,12:1
18American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth显示文摘Duda RB Zhong Y Navas V 1999J Surg Oncol1999,72,:1
19Diffusion of ethylbenzene in molten polystyrene显示文摘Duda J L Ni Y C Vrentas J S 1978J Appl Polym Sci1978,22,3:1
20Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants显示文摘CLEMENTS-MANN ML DUDAS R HOSHINO Y 2001Vaccine2001,19,32:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费